| abstract |
A compound of formula I as defined below and defined herein: Pharmaceutically acceptable salts, composites, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune diseases that are mediated at least in part by Breton tyrosine kinase (BTK). |